Evidence map›Paper›PMID 33712588›Full record

ArticleNature communications2021

Human-interpretable image features derived from densely mapped cancer pathology slides predict diverse molecular phenotypes.

James A Diao, Jason K Wang, Wan Fung Chui, Victoria Mountain, Sai Chowdary Gullapally, Ramprakash Srinivasan, Richard N Mitchell, Benjamin Glass, Sara Hoffman, Sudha K Rao and 12 more

Abstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 124 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
124citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

124 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

64 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

James A Diao *PathAI, Inc., Boston, MA, USA.ORCID 0000-0002-6134-4339
Jason K Wang *PathAI, Inc., Boston, MA, USA.
Wan Fung Chui *PathAI, Inc., Boston, MA, USA.ORCID 0000-0002-9576-9378
Victoria MountainPathAI, Inc., Boston, MA, USA.
Sai Chowdary GullapallyPathAI, Inc., Boston, MA, USA.
Ramprakash SrinivasanPathAI, Inc., Boston, MA, USA.
Richard N MitchellProgram in Health Sciences and Technology, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-0329-7618
Benjamin GlassPathAI, Inc., Boston, MA, USA.
Sara HoffmanPathAI, Inc., Boston, MA, USA.
Sudha K RaoPathAI, Inc., Boston, MA, USA.
Chirag MaheshwariPathAI, Inc., Boston, MA, USA.
Abhik LahiriPathAI, Inc., Boston, MA, USA.
Aaditya PrakashPathAI, Inc., Boston, MA, USA.
Ryan McLoughlinPathAI, Inc., Boston, MA, USA.
Jennifer K KernerPathAI, Inc., Boston, MA, USA.
Murray B ResnickPathAI, Inc., Boston, MA, USA.
Michael C MontaltoPathAI, Inc., Boston, MA, USA.
Aditya KhoslaPathAI, Inc., Boston, MA, USA.
Ilan N WapinskiPathAI, Inc., Boston, MA, USA.
Andrew H Beck *PathAI, Inc., Boston, MA, USA. andy.beck@pathai.com.ORCID 0000-0002-9978-134X
Hunter L Elliott *PathAI, Inc., Boston, MA, USA.
Amaro Taylor-Weiner *PathAI, Inc., Boston, MA, USA. amaro.taylor@pathai.com.

Funding

Training Program in Bioinformatics and Integrative GenomicsT32HG002295 · NHGRI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Peter J Park · 2001 to 2026
$15.8M
NHGRI NIH HHS T32 HG002295
6 · The paper itself

Abstract

Computational methods have made substantial progress in improving the accuracy and throughput of pathology workflows for diagnostic, prognostic, and genomic prediction. Still, lack of interpretability remains a significant barrier to clinical integration. We present an approach for predicting clinically-relevant molecular phenotypes from whole-slide histopathology images using human-interpretable image features (HIFs). Our method leverages >1.6 million annotations from board-certified pathologists across >5700 samples to train deep learning models for cell and tissue classification that can exhaustively map whole-slide images at two and four micron-resolution. Cell- and tissue-type model outputs are combined into 607 HIFs that quantify specific and biologically-relevant characteristics across five cancer types. We demonstrate that these HIFs correlate with well-known markers of the tumor microenvironment and can predict diverse molecular signatures (AUROC 0.601-0.864), including expression of four immune checkpoint proteins and homologous recombination deficiency, with performance comparable to 'black-box' methods. Our HIF-based approach provides a comprehensive, quantitative, and interpretable window into the composition and spatial architecture of the tumor microenvironment.

Indexed as

PhenotypeAlgorithmsDeep LearningHumansImage Processing, Computer-AssistedNeoplasmsPathology, MolecularPrecision MedicineTumor Microenvironment

Identifiers

PMID33712588
PMCPMC7955068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.